Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

A double-blind, randomised, crossover trial of two botulinum toxin type a in patients with spasticity.

Guarany FC, Picon PD, Guarany NR, dos Santos AC, Chiella BP, Barone CR, Fendt LC, Schestatsky P.

PLoS One. 2013;8(2):e56479. doi: 10.1371/journal.pone.0056479. Epub 2013 Feb 28.

PMID:
23468866
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.

Shaw L, Rodgers H, Price C, van Wijck F, Shackley P, Steen N, Barnes M, Ford G, Graham L; BoTULS investigators.

Health Technol Assess. 2010 May;14(26):1-113, iii-iv. doi: 10.3310/hta14260.

PMID:
20515600
[PubMed - indexed for MEDLINE]
Free Article
3.

A double-blind, randomized, crossover study of prosigne versus botox in patients with blepharospasm and hemifacial spasm.

Rieder CR, Schestatsky P, Socal MP, Monte TL, Fricke D, Costa J, Picon PD.

Clin Neuropharmacol. 2007 Jan-Feb;30(1):39-42.

PMID:
17272968
[PubMed - indexed for MEDLINE]
4.

A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke.

Bakheit AM, Pittock S, Moore AP, Wurker M, Otto S, Erbguth F, Coxon L.

Eur J Neurol. 2001 Nov;8(6):559-65.

PMID:
11784339
[PubMed - indexed for MEDLINE]
5.

Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial.

Kaji R, Osako Y, Suyama K, Maeda T, Uechi Y, Iwasaki M; GSK1358820 Spasticity Study Group.

J Neurol. 2010 Aug;257(8):1330-7. doi: 10.1007/s00415-010-5526-3. Epub 2010 Apr 1. Erratum in: J Neurol. 2010 Aug;257(8):1416.

PMID:
20358216
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Rationale and design of a multicentre, double-blind, prospective, randomized, European and Canadian study: evaluating patient outcomes and costs of managing adults with post-stroke focal spasticity.

Borg J, Ward AB, Wissel J, Kulkarni J, Sakel M, Ertzgaard P, Åkerlund P, Reuter I, Herrmann C, Satkunam L, Wein T, Girod I, Wright N; BEST Study Group.

J Rehabil Med. 2011 Jan;43(1):15-22. doi: 10.2340/16501977-0663.

PMID:
21174051
[PubMed - indexed for MEDLINE]
Free Article
7.

Does botulinum toxin type A decrease pain and lessen disability in hemiplegic survivors of stroke with shoulder pain and spasticity?: a randomized, double-blind, placebo-controlled trial.

Marciniak CM, Harvey RL, Gagnon CM, Duraski SA, Denby FA, McCarty S, Bravi LA, Polo KM, Fierstein KM.

Am J Phys Med Rehabil. 2012 Dec;91(12):1007-19. doi: 10.1097/PHM.0b013e31826ecb02.

PMID:
23064478
[PubMed - indexed for MEDLINE]
8.

[Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].

Wissel J, Entner T.

Wien Klin Wochenschr. 2001;113 Suppl 4:20-4. Review. German.

PMID:
15506048
[PubMed - indexed for MEDLINE]
9.

A prospective, randomized, double-blind study comparing the efficacy and safety of type a botulinum toxins botox and prosigne in the treatment of cervical dystonia.

Quagliato EM, Carelli EF, Viana MA.

Clin Neuropharmacol. 2010 Jan-Feb;33(1):22-6. doi: 10.1097/WNF.0b013e3181c46f48.

PMID:
19959960
[PubMed - indexed for MEDLINE]
10.

Can botulinum toxin decrease carer burden in long term care residents with upper limb spasticity? A randomized controlled study.

Lam K, Lau KK, So KK, Tam CK, Wu YM, Cheung G, Liang KS, Yeung KM, Lam KY, Yui S, Leung C.

J Am Med Dir Assoc. 2012 Jun;13(5):477-84. doi: 10.1016/j.jamda.2012.03.005. Epub 2012 Apr 20.

PMID:
22521630
[PubMed - indexed for MEDLINE]
11.

Upper extremity spasticity in children with cerebral palsy: a randomized, double-blind, placebo-controlled study of the short-term outcomes of treatment with botulinum A toxin.

Koman LA, Smith BP, Williams R, Richardson R, Naughton M, Griffin L, Evans P.

J Hand Surg Am. 2013 Mar;38(3):435-46.e1. doi: 10.1016/j.jhsa.2012.12.019.

PMID:
23428186
[PubMed - indexed for MEDLINE]
12.

Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial.

Rosales RL, Kong KH, Goh KJ, Kumthornthip W, Mok VC, Delgado-De Los Santos MM, Chua KS, Abdullah SJ, Zakine B, Maisonobe P, Magis A, Wong KS.

Neurorehabil Neural Repair. 2012 Sep;26(7):812-21. doi: 10.1177/1545968311430824. Epub 2012 Feb 27.

PMID:
22371239
[PubMed - indexed for MEDLINE]
13.

Treatment of upper limb spasticity after stroke: one-year safety and efficacy of botulinum toxin type A NT201.

Fiore P, Santamato A, Ranieri M, Bellomo RG, Saggini R, Panza F, Megna G, Cristella G, Megna M.

Int J Immunopathol Pharmacol. 2012 Jan-Mar;25(1 Suppl):57S-62S.

PMID:
22652163
[PubMed - indexed for MEDLINE]
14.

Prospective, randomized, double-blind study, comparing botulinum toxins type a botox and prosigne for blepharospasm and hemifacial spasm treatment.

Quagliato EM, Carelli EF, Viana MA.

Clin Neuropharmacol. 2010 Jan-Feb;33(1):27-31. doi: 10.1097/WNF.0b013e3181c46f61.

PMID:
20124784
[PubMed - indexed for MEDLINE]
15.

Botulinum toxin A (Dysport®): in dystonias and focal spasticity.

Keam SJ, Muir VJ, Deeks ED.

Drugs. 2011 May 28;71(8):1043-58. doi: 10.2165/11206340-000000000-00000. Review.

PMID:
21668041
[PubMed - indexed for MEDLINE]
16.

Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial.

Bhakta BB, Cozens JA, Chamberlain MA, Bamford JM.

J Neurol Neurosurg Psychiatry. 2000 Aug;69(2):217-21. Erratum in: J Neurol Neurosurg Psychiatry 2001 Jun;70(6):821.

PMID:
10896696
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Botulinum toxin A in the management of spastic gait disorders in children and young adults with cerebral palsy: a randomized, double-blind study of "high-dose" versus "low-dose" treatment.

Wissel J, Heinen F, Schenkel A, Doll B, Ebersbach G, Müller J, Poewe W.

Neuropediatrics. 1999 Jun;30(3):120-4.

PMID:
10480205
[PubMed - indexed for MEDLINE]
18.

Botulinum toxin type A in post-stroke upper limb spasticity.

Kaji R, Osako Y, Suyama K, Maeda T, Uechi Y, Iwasaki M; GSK1358820 Spasticity Study Group.

Curr Med Res Opin. 2010 Aug;26(8):1983-92. doi: 10.1185/03007995.2010.497103.

PMID:
20569068
[PubMed - indexed for MEDLINE]
19.

Evidence-based systematic review on the efficacy and safety of botulinum toxin-A therapy in post-stroke spasticity.

Rosales RL, Chua-Yap AS.

J Neural Transm. 2008;115(4):617-23. doi: 10.1007/s00702-007-0869-3. Epub 2008 Mar 6. Review.

PMID:
18322637
[PubMed - indexed for MEDLINE]
20.

Botulinum toxin A for spasticity, muscle spasms, and rigidity.

Grazko MA, Polo KB, Jabbari B.

Neurology. 1995 Apr;45(4):712-7.

PMID:
7723960
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk